Pharmaceutical formulations of FCRN inhibitors suitable for subcutaneous administration

MA56102AUndetermined Publication Date: 2022-04-13ARGENX BVBA(BE)

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA56102
Authority / Receiving Office: MA · MA
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2019-06-07
Filing Date: 2020-06-05
Publication Date: 2022-04-13

Application Information

Patent Timeline

07 Jun 2019

Priority

05 Jun 2020

Application

MA56102

13 Apr 2022

Publication

MA56102A

IPC: A61K39/395; C07K16/00

CPC: A61K39/39591; A61K47/183; A61K47/26; A61K47/22; A61K9/0019; A61K9/08; A61K47/02; A61K47/20

Inventors: BORGIONS Filip; LEMOULT Stephanie

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Need to check novelty before this filing date? Find Prior Art

No text content released.